Advocacy intelligence hub — real-time data for patient organizations
Antev Ltd. — PHASE2
University of Chicago — NA
Gustave Roussy, Cancer Campus, Grand Paris — PHASE2
National Taiwan University Hospital — PHASE2
Debiopharm International SA — PHASE2
Xiaojun Chen — PHASE2, PHASE3
Xiaojun Chen — PHASE2, PHASE3
Fudan University — PHASE2
Aadi Bioscience, Inc. — PHASE2
Janssen Pharmaceutica N.V., Belgium — PHASE3
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs